What risks or side effects are associated with SPRINT PNS?

The most common adverse event reported in clinical studies was skin irritation due to components being adhered to the skin (which may include inflammation, mild blistering, and/or redness). Other less-reported events included itching at the lead exit site, pain after lead placement and infection. The majority of the adverse events in clinical studies were resolved with little to no intervention within a few days, and none were classified as serious. Similar adverse events have been reported outside of clinical studies. Infections have been reported for 1-2% of patients. Serious adverse events have been rare.

It is possible that a piece of the MicroLead may remain beneath your skin following the treatment. If this happens, your physician will discuss with you whether the piece should be removed. Surgical removal of a piece of the MicroLead is rarely advised, as most instances pose little to no risk. Find full safety information here.